{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-15T12:20:38.156839+00:00",
  "news": [
    {
      "title": "Jim Cramer Shows Confidence in Amgen - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOSGZPRnp1V0lmZFZiaW5mRG1vWGQ0R0E4MlpwMTVvbFhycGdMbGQ2LWZ0UkZpSG84V2podFI5eU9vbEUxUU5VdW9WWGFUc3BIa01DRXZFT1dQbGl3aEZlZUcyUGRIRlloc0N3akNpWjhIUURxZjZwRy1KdzM0NGVNbmY3VU10Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxOSGZPRnp1V0lmZFZiaW5mRG1vWGQ0R0E4MlpwMTVvbFhycGdMbGQ2LWZ0UkZpSG84V2podFI5eU9vbEUxUU5VdW9WWGFUc3BIa01DRXZFT1dQbGl3aEZlZUcyUGRIRlloc0N3akNpWjhIUURxZjZwRy1KdzM0NGVNbmY3VU10Zw?oc=5\" target=\"_blank\">Jim Cramer Shows Confidence in Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-13T17:09:43+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Survey shows 'cardiology deserts' at heart of Amgen-backed drive - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPVkZXOEtoTkNMTzExUnN2TVBXX0FTSEhzTTNYdmdEdFMtb29FSkNOV3I5YVh0cTVrdU45VFd1UExrUWp3dXRUNld3OFJMczlHQ21JR0R1RWt1elAwSDgxQnh3N2p6UzlsbzFwQVlvNlUtd3YxdTg2bXpmSzNrVnZyeE9faFdGb2pyWVRqam0yVWhSZEZDUF9Ed0ZvSl9PTEhLMWc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVkZXOEtoTkNMTzExUnN2TVBXX0FTSEhzTTNYdmdEdFMtb29FSkNOV3I5YVh0cTVrdU45VFd1UExrUWp3dXRUNld3OFJMczlHQ21JR0R1RWt1elAwSDgxQnh3N2p6UzlsbzFwQVlvNlUtd3YxdTg2bXpmSzNrVnZyeE9faFdGb2pyWVRqam0yVWhSZEZDUF9Ed0ZvSl9PTEhLMWc?oc=5\" target=\"_blank\">Survey shows 'cardiology deserts' at heart of Amgen-backed drive</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-11-14T14:45:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Why Amgen Stock Edged Past the Market on Thursday - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOeFVsclhhY182a0hBSFNacXQ1d281c3hjUWc0anBDZ3hKQXNvMExPemNqaDM1UmJjT3dCV2dRT2tWc2hLN0VMWXdoZDVLTUh5NGMzVGVHa0t4a1NrVmR2WTFfcXhaWTJfVy1tTFpjd0o1NjVwVlAwR1lLdTN2N3V6blFZQWxQaTVrdXZaUmhWd2I1WlNibE1B?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOeFVsclhhY182a0hBSFNacXQ1d281c3hjUWc0anBDZ3hKQXNvMExPemNqaDM1UmJjT3dCV2dRT2tWc2hLN0VMWXdoZDVLTUh5NGMzVGVHa0t4a1NrVmR2WTFfcXhaWTJfVy1tTFpjd0o1NjVwVlAwR1lLdTN2N3V6blFZQWxQaTVrdXZaUmhWd2I1WlNibE1B?oc=5\" target=\"_blank\">Why Amgen Stock Edged Past the Market on Thursday</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-11-13T22:36:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "A Closer Look at Amgen's Options Market Dynamics - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxQU0VYWUZSaXhpdmhIZElOVERsaVVNVzFqX1paM1BER1pUR1lCVmRCRnNydDhZN3B0LWYzSUJ3cjl5R3YyQVg2Rm1ONVl1ckFXenRfMGlfVGZMQndoR3BMU01oSlBqTFhYdXVlSDNrYjRaY2dES053WjdhaU1JZzl0UE14cWlEaVBlSFNoOWEzRlp1LXpfX3FrVnlIUDY0bENDOUxBT1J6Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxQU0VYWUZSaXhpdmhIZElOVERsaVVNVzFqX1paM1BER1pUR1lCVmRCRnNydDhZN3B0LWYzSUJ3cjl5R3YyQVg2Rm1ONVl1ckFXenRfMGlfVGZMQndoR3BMU01oSlBqTFhYdXVlSDNrYjRaY2dES053WjdhaU1JZzl0UE14cWlEaVBlSFNoOWEzRlp1LXpfX3FrVnlIUDY0bENDOUxBT1J6Zw?oc=5\" target=\"_blank\">A Closer Look at Amgen's Options Market Dynamics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2025-11-13T15:02:25+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxNRGdNeEUya1hxdk44enkwZER3Qkt5UkZYaDJyM29IYXNZcWZXSlpqdEhDN1lGMWpvUUpOYWZIMzdNRmhJMmZubGNvaFcwMDR2V3B1XzVSSC1VTThJeFJqb3BCRl9DalNPZ1lWdjhqNFFEM19oeWJLY1VBQy12RzRUTG0xSW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxNRGdNeEUya1hxdk44enkwZER3Qkt5UkZYaDJyM29IYXNZcWZXSlpqdEhDN1lGMWpvUUpOYWZIMzdNRmhJMmZubGNvaFcwMDR2V3B1XzVSSC1VTThJeFJqb3BCRl9DalNPZ1lWdjhqNFFEM19oeWJLY1VBQy12RzRUTG0xSW8?oc=5\" target=\"_blank\">Amgen’s (AMGN) Cholesterol Drug Is Very Important, Says JIm Cramer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-12T18:07:53+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxNWlZYNE1jbDZBQkJuelBaSnR0bFFqTXprSm9TSDJ5V2dVY0FYMVJwMGhndlFoaHFGOE5PNko3Qm5Ba2ZJdFdzckpFSVBfcWxNUEtWRmRidzlTalRZLUxzSjFSY2dNV25GMDRjSTF6VjVyUk1WZ3cyMmZCalloN3BWcDBVTnRKN2tMblE?oc=5\" target=\"_blank\">Amgen’s cholesterol shot prevented first heart attacks and strokes, more detailed data affirm</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-08T15:10:39+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen cholesterol drug cuts risk of first cardiac event by 25% - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5\" target=\"_blank\">Amgen cholesterol drug cuts risk of first cardiac event by 25%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-08T15:30:17+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T13:36:48+00:00",
      "source": "TradingView"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-14",
      "close": 336.739990234375
    },
    "history": [
      {
        "date": "2025-11-06",
        "close": 315.5899963378906
      },
      {
        "date": "2025-11-07",
        "close": 320.20001220703125
      },
      {
        "date": "2025-11-10",
        "close": 323.6600036621094
      },
      {
        "date": "2025-11-11",
        "close": 338.45001220703125
      },
      {
        "date": "2025-11-12",
        "close": 336.2799987792969
      },
      {
        "date": "2025-11-13",
        "close": 336.0
      },
      {
        "date": "2025-11-14",
        "close": 336.739990234375
      }
    ],
    "name": "Amgen Inc."
  }
}